Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$12.42 -0.3%	$11.29	$4.88 ▼ $13.14	$1.82B	1.06	2.05 million shs	1.78 million shs
ATRC AtriCure	$34.54 +1.3%	$32.30	$18.94 ▼ $43.11	$1.71B	1.57	649,103 shs	491,968 shs
ITGR Integer	$118.86 -0.5%	$118.60	$104.93 ▼ $146.36	$4.15B	1.03	373,948 shs	377,531 shs
TFX Teleflex	$122.19 -0.3%	$129.59	$119.08 ▼ $249.91	$5.41B	1.17	629,565 shs	683,821 shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	-0.32%	-0.24%	+13.11%	-0.88%	+21.41%
ATRC AtriCure	+1.35%	+5.59%	+15.48%	-10.84%	+59.83%
ITGR Integer	-0.52%	+0.37%	-5.91%	-3.37%	-2.06%
TFX Teleflex	-0.04%	+1.03%	-10.86%	-7.84%	-39.66%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEC Alphatec	4.1234 of 5 stars	3.4	1.0	0.0	3.3	3.1	4.2	0.6
ATRC AtriCure	3.6518 of 5 stars	4.5	3.0	0.0	0.0	2.9	2.5	0.6
ITGR Integer	3.0355 of 5 stars	3.5	3.0	0.0	0.0	2.2	2.5	1.3
TFX Teleflex	4.8861 of 5 stars	4.0	4.0	2.5	3.9	2.4	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	2.89	Moderate Buy	$17.89	44.03% Upside
ATRC AtriCure	3.00	Buy	$50.67	46.69% Upside
ITGR Integer	3.00	Buy	$145.00	21.99% Upside
TFX Teleflex	2.09	Hold	$164.63	34.73% Upside

Current Analyst Ratings Breakdown

Latest ATRC, TFX, ITGR, and ATEC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	ITGR Integer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy	$133.00 ➝ $140.00
5/5/2025	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$140.00 ➝ $137.00
5/5/2025	TFX Teleflex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$191.00 ➝ $173.00
5/2/2025	ATEC Alphatec	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$13.00 ➝ $15.00
5/2/2025	ATEC Alphatec	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $16.00
5/2/2025	TFX Teleflex	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$150.00 ➝ $145.00
5/2/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$146.00 ➝ $137.00
4/30/2025	ATRC AtriCure	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$60.00 ➝ $60.00
4/30/2025	ATRC AtriCure	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$60.00 ➝ $58.00
4/30/2025	ATRC AtriCure	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$51.00 ➝ $44.00
4/25/2025	ITGR Integer	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$140.00 ➝ $150.00

(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$642.27M	2.83	N/A	N/A	$0.57 per share	21.79
ATRC AtriCure	$480.08M	3.56	N/A	N/A	$9.46 per share	3.65
ITGR Integer	$1.75B	2.38	$7.83 per share	15.18	$48.27 per share	2.46
TFX Teleflex	$3.01B	1.79	$13.14 per share	9.30	$94.49 per share	1.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$186.64M	-$1.15	N/A	N/A	N/A	-31.06%	-541.39%	-22.99%	7/30/2025 (Estimated)
ATRC AtriCure	-$44.70M	-$0.81	N/A	N/A	N/A	-9.61%	-6.80%	-5.19%	7/29/2025 (Estimated)
ITGR Integer	$90.65M	$2.11	35.38	17.87	1.72	6.92%	11.65%	5.89%	7/24/2025 (Estimated)
TFX Teleflex	$356.33M	$3.17	24.29	8.05	1.73	7.85%	14.19%	8.53%	8/7/2025 (Estimated)

Latest ATRC, TFX, ITGR, and ATEC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	Q1 2025	ATEC Alphatec	-$0.12	-$0.35	-$0.23	-$0.35	$167.57 million	$169.18 million
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
4/29/2025	Q1 2025	ATRC AtriCure	-$0.25	-$0.14	+$0.11	-$0.14	$122.92 million	$123.62 million
4/24/2025	Q1 2025	ITGR Integer	$1.27	$1.31	+$0.04	-$0.66	$428.51 million	$437.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
ATRC AtriCure	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.11%	N/A	42.90%	N/A

Latest ATRC, TFX, ITGR, and ATEC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	30.21	2.32	1.15
ATRC AtriCure	0.13	3.65	2.62
ITGR Integer	0.62	2.95	2.09
TFX Teleflex	0.37	2.42	1.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
ATRC AtriCure	99.11%
ITGR Integer	99.29%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	20.90%
ATRC AtriCure	3.50%
ITGR Integer	2.16%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	146.17 million	109.48 million	Optionable
ATRC AtriCure	1,050	49.51 million	47.32 million	Optionable
ITGR Integer	10,000	34.89 million	32.87 million	Optionable
TFX Teleflex	15,500	44.19 million	45.78 million	Optionable

ATRC, TFX, ITGR, and ATEC Headlines

Recent News About These Companies

7,507 Shares in Teleflex Incorporated (NYSE:TFX) Bought by Siemens Fonds Invest GmbH

May 30 at 5:14 AM | marketbeat.com

Mackenzie Financial Corp Buys 13,488 Shares of Teleflex Incorporated (NYSE:TFX)

May 30 at 4:35 AM | marketbeat.com

Voloridge Investment Management LLC Takes Position in Teleflex Incorporated (NYSE:TFX)

May 28 at 4:47 AM | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 40,128 Shares of Teleflex Incorporated (NYSE:TFX)

May 27, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Position Trimmed by Quantinno Capital Management LP

May 27, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Receives $164.63 Average PT from Analysts

May 27, 2025 | americanbankingnews.com

Teleflex Incorporated (NYSE:TFX) Shares Bought by Ameriprise Financial Inc.

May 27, 2025 | marketbeat.com

Jane Street Group LLC Cuts Stock Position in Teleflex Incorporated (NYSE:TFX)

May 26, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Analysts

May 26, 2025 | marketbeat.com

Worldquant Millennium Advisors LLC Purchases New Shares in Teleflex Incorporated (NYSE:TFX)

May 25, 2025 | marketbeat.com

Squarepoint Ops LLC Raises Position in Teleflex Incorporated (NYSE:TFX)

May 25, 2025 | marketbeat.com

Nuveen Asset Management LLC Trims Stock Holdings in Teleflex Incorporated (NYSE:TFX)

May 25, 2025 | marketbeat.com

Woodline Partners LP Lowers Holdings in Teleflex Incorporated (NYSE:TFX)

May 23, 2025 | marketbeat.com

Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

May 22, 2025 | globenewswire.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 21, 2025 | accessnewswire.com

3 Healthcare Stocks with Questionable Fundamentals

May 21, 2025 | msn.com

Cresset Asset Management LLC Sells 5,188 Shares of Teleflex Incorporated (NYSE:TFX)

May 21, 2025 | marketbeat.com

Janus Henderson Enterprise Fund Q1 2025 Commentary

May 20, 2025 | seekingalpha.com

Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

May 20, 2025 | prnewswire.com

Millennium Management LLC Has $44.51 Million Position in Teleflex Incorporated (NYSE:TFX)

May 20, 2025 | marketbeat.com

Equities Analysts Offer Predictions for Teleflex Q3 Earnings

May 20, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATRC, TFX, ITGR, and ATEC Company Descriptions

Alphatec NASDAQ:ATEC

$12.42 -0.04 (-0.32%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$12.48 +0.06 (+0.48%)

As of 05/30/2025 06:32 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

AtriCure NASDAQ:ATRC

$34.54 +0.46 (+1.35%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$34.56 +0.02 (+0.07%)

As of 05/30/2025 07:57 PM Eastern

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Integer NYSE:ITGR

$118.86 -0.63 (-0.53%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$118.76 -0.09 (-0.08%)

As of 05/30/2025 04:45 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Teleflex NYSE:TFX

$122.19 -0.34 (-0.28%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$122.82 +0.63 (+0.51%)

As of 05/30/2025 06:43 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time